Viemed Healthcare, Inc.

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: CA92663R1055
USD
9.35
0.17 (1.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

229.45 k

Shareholding (Dec 2025)

FII

7.07%

Held by 52 FIIs

DII

70.27%

Held by 27 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 15.81%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 17.50

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 15.95%

 
4

The company has declared Positive results for the last 3 consecutive quarters

5

With ROE of 10.99%, it has a expensive valuation with a 2.83 Price to Book Value

6

High Institutional Holdings at 83.01%

7

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

USD 378 Million (Micro Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

10.99%

stock-summary
Price to Book

2.83

Revenue and Profits:
Net Sales:
76 Million
(Quarterly Results - Dec 2025)
Net Profit:
6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.08%
0%
28.08%
6 Months
37.91%
0%
37.91%
1 Year
28.08%
0%
28.08%
2 Years
2.19%
0%
2.19%
3 Years
-8.33%
0%
-8.33%
4 Years
47.94%
0%
47.94%
5 Years
-18.7%
0%
-18.7%

Viemed Healthcare, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.95%
EBIT Growth (5y)
0.10%
EBIT to Interest (avg)
17.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.56
Tax Ratio
28.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
83.01%
ROCE (avg)
19.50%
ROE (avg)
15.81%

Valuation key factors

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.83
EV to EBIT
21.13
EV to EBITDA
8.49
EV to Capital Employed
2.68
EV to Sales
1.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.71%
ROE (Latest)
10.99%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 43 Schemes (22.43%)

Foreign Institutions

Held by 52 Foreign Institutions (7.07%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.98% vs 13.95% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 61.11% vs 9.09% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76.20",
          "val2": "71.90",
          "chgp": "5.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.40",
          "val2": "14.50",
          "chgp": "13.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.50",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.80",
          "chgp": "87.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.80",
          "val2": "3.60",
          "chgp": "61.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.50%",
          "val2": "96.90%",
          "chgp": "1.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.51% vs 22.57% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 35.09% vs 11.76% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "270.30",
          "val2": "224.30",
          "chgp": "20.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "50.40",
          "val2": "40.30",
          "chgp": "25.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.80",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "-0.40",
          "chgp": "-175.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.40",
          "val2": "11.40",
          "chgp": "35.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "80.80%",
          "val2": "72.90%",
          "chgp": "0.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
76.20
71.90
5.98%
Operating Profit (PBDIT) excl Other Income
16.40
14.50
13.10%
Interest
0.40
0.50
-20.00%
Exceptional Items
-0.10
-0.80
87.50%
Consolidate Net Profit
5.80
3.60
61.11%
Operating Profit Margin (Excl OI)
115.50%
96.90%
1.86%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.98% vs 13.95% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 61.11% vs 9.09% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
270.30
224.30
20.51%
Operating Profit (PBDIT) excl Other Income
50.40
40.30
25.06%
Interest
1.20
0.80
50.00%
Exceptional Items
-1.10
-0.40
-175.00%
Consolidate Net Profit
15.40
11.40
35.09%
Operating Profit Margin (Excl OI)
80.80%
72.90%
0.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 20.51% vs 22.57% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 35.09% vs 11.76% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details